UBA2 and colorectal carcinoma: Further basic experiments exhibited that downregulated UBA2 could significantly inhibit the proliferation of CRC cell lines in vitro and suppress tumor growth in vivo [25], and butyrate could interrupt the metabolism of CRC cells and ultimately result in the suppression of cell proliferation by targeting pyruvate kinase M2, thus suppressing the development of CRC [26].